Success StoriesOdyssey Therapeutics Climbs 11% After $304 Million IPOOdyssey Therapeutics climbs 11% after a $304 million US IPO, signaling strong investor confidence in its innovative ther…Marcus Rivera·May 10, 2026, 2:01 AM